Drug intelligence / Profile preview

withanone

Development stage
Preclinical
Lead developer
Patanjali Research Institute
Modality
Small Molecules
Administration
Oral
01

Overview

Withanone is a naturally occurring withanolide, a C28-steroidal lactone primarily derived from the medicinal plant *Withania somnifera* (Ashwagandha). It is recognized as a potent inhibitor of the mitochondrial chaperone protein GRP75 (also known as mortalin or HSPA9). By binding to GRP75, withanone disrupts its interaction with various proteins, such as p53, thereby inducing apoptosis in cancer cells or modulating cellular stress responses. Recent research has also identified its role in preventing CD28 internalization in T cells by inhibiting GRP75-mediated macropinocytosis, suggesting potential therapeutic applications in heart failure and immune dysregulation. While widely available as a component of dietary supplements, it is extensively utilized in preclinical research for its anti-cancer, neuroprotective, and anti-inflammatory properties.

Other names
6α,7α-epoxy-5α,17α-dihydroxy-1-oxowitha-2,24-dienolidemortalin inhibitor
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)CDKN1A (Cyclin-dependent kinase inhibitor 1A)HSPA9 (Heat shock protein family A member 9)Heat shock 70 kDa protein 9-Tumor protein p53 protein-protein interaction interface (Mortalin-p53 PPI)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on withanone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on withanone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call